Connecticut Transit (CTTRANSIT) implemented random drug and alcohol testing of its nearly 700 safety-sensitive bus operators and mechanics in September 1990. The CTTRANSIT experience to date is summarised with particular reference to the accuracy and reliability of test results. During the first 17 months of this program, the rate of positive results was 1.91 percent. Significantly, zero false-positive results have occurred among the more than 500 random tests to date at CTTRANSIT. This performance is attributed in large measure to several critical quality-control measures, including confirmation of all initial positive tests using state-of-the-art gas chromatography/mass spectrometry technology, use of a National Institute of Drug Abuse-certified laboratory, and validation of test results by a medical review officer. Other key features of the CTTRANSIT program are detailed. Three important underpinnings of the program at CTTRANSIT include legal authority under a state random testing statute, the company's long-standing drug and alcohol policies, and a nationally recognised employee assistance program. Random testing at CTTRANSIT was specifically upheld in a landmark grievance arbitration award. (Author/publisher)
Abstract